Pfizer is feeling sales pressure on its megablockbuster pneumococcal vaccine, Prevnar 13, but behind that big-selling shot are several pipeline candidates it is counting on to propel future vaccines growth.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,